Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data suggest talactoferrin reduces mortality in severe sepsis

June 2, 2010

Phase IIb safety and efficacy data presented on MP-376 in cystic fibrosis

June 2, 2010

Ad3-hTERT-E1A shows favorable clinical safety in solid tumors

June 2, 2010

Auto TAG vaccine shows clinical benefit in advanced cancer

June 2, 2010

GSK-256066 safe and well tolerated in patients with COPD

June 2, 2010

Synergy of ipilimumab and androgen ablation reported in prostate cancer

June 1, 2010

HRH1 gene SNP may predict response to OFC in depressed individuals

June 1, 2010

KB-001 shows clinical promise in P. aeruginosa infection

June 1, 2010

Flibanserin improves HSDD symptoms in premenopausal women

June 1, 2010

Tranexamic acid tablets reduce menstrual blood loss in clinical trials

May 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...